Stocktoria
RHYTHM PHARMACEUTICALS, INC. RYTM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-10-05
RHYTHM PHARMACEUTICALS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $189.8M | $130.1M | $77.4M | $23.6M | $3.2M |
| R&D expense | $167.3M | $238.0M | $135.0M | $108.6M | $104.1M |
| SG&A expense | $194.9M | $144.3M | $117.5M | $92.0M | $68.5M |
| Operating income | -$192.0M | -$265.5M | -$184.4M | -$179.2M | -$170.1M |
| Interest expense | — | — | $13.9M | $5.2M | — |
| Income tax | $497,000 | $346,000 | $564,000 | — | — |
| Net income | -$196.5M | -$260.6M | -$184.7M | -$181.1M | -$69.6M |
| EPS (diluted) | $-3.11 | $-4.34 | $-3.20 | $-3.47 | $-1.40 |
| Operating cash flow | -$115.7M | -$113.9M | -$136.2M | -$173.4M | -$146.0M |
| Free cash flow | -$116.6M | -$113.9M | -$136.2M | -$173.7M | -$146.4M |
| Cash & equivalents | $54.3M | $89.1M | $60.1M | $127.7M | $59.2M |
| Inventory | $25.8M | $18.7M | $8.6M | $2.9M | $111,000 |
| Total assets | $480.2M | $392.3M | $332.7M | $382.5M | $329.5M |
| Total liabilities | $210.2M | $227.7M | $163.0M | $118.2M | $45.4M |
| Shareholders' equity | $139.1M | $21.7M | $169.8M | $264.3M | $284.2M |
Source: SEC EDGAR filings · CIK 0001649904 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.